These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 29367207

  • 1. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.
    Ibrahim SH, Hirsova P, Gores GJ.
    Gut; 2018 May; 67(5):963-972. PubMed ID: 29367207
    [Abstract] [Full Text] [Related]

  • 2. Nonalcoholic Steatohepatitis.
    Suzuki A, Diehl AM.
    Annu Rev Med; 2017 Jan 14; 68():85-98. PubMed ID: 27732787
    [Abstract] [Full Text] [Related]

  • 3. Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis.
    Hirsova P, Ibrabim SH, Gores GJ, Malhi H.
    J Lipid Res; 2016 Oct 14; 57(10):1758-1770. PubMed ID: 27049024
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC, Haczeyni F, Chitturi S.
    Adv Exp Med Biol; 2018 Oct 14; 1061():19-44. PubMed ID: 29956204
    [Abstract] [Full Text] [Related]

  • 5. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ.
    Gastroenterology; 2016 Apr 14; 150(4):956-67. PubMed ID: 26764184
    [Abstract] [Full Text] [Related]

  • 6. Lipid mediators of liver injury in nonalcoholic fatty liver disease.
    Liangpunsakul S, Chalasani N.
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan 01; 316(1):G75-G81. PubMed ID: 30383414
    [Abstract] [Full Text] [Related]

  • 7. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Dasgupta D, Nakao Y, Mauer AS, Thompson JM, Sehrawat TS, Liao CY, Krishnan A, Lucien F, Guo Q, Liu M, Xue F, Fukushima M, Katsumi T, Bansal A, Pandey MK, Maiers JL, DeGrado T, Ibrahim SH, Revzin A, Pavelko KD, Barry MA, Kaufman RJ, Malhi H.
    Gastroenterology; 2020 Oct 01; 159(4):1487-1503.e17. PubMed ID: 32574624
    [Abstract] [Full Text] [Related]

  • 8. Nonalcoholic Steatohepatitis Promoting Kinases.
    Ibrahim SH, Hirsova P, Malhi H, Gores GJ.
    Semin Liver Dis; 2020 Nov 01; 40(4):346-357. PubMed ID: 32526787
    [Abstract] [Full Text] [Related]

  • 9. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G, Pierantonelli I, Torquato P, Marinelli R, Ferreri C, Chatgilialoglu C, Bartolini D, Galli F.
    Free Radic Biol Med; 2019 Nov 20; 144():293-309. PubMed ID: 31152791
    [Abstract] [Full Text] [Related]

  • 10. CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.
    Lei Z, Yu J, Wu Y, Shen J, Lin S, Xue W, Mao C, Tang R, Sun H, Qi X, Wang X, Xu L, Wei C, Wang X, Chen H, Hao P, Yin W, Zhu J, Li Y, Wu Y, Liu S, Liang H, Chen X, Su C, Zhou S.
    J Hepatol; 2024 Feb 20; 80(2):194-208. PubMed ID: 38438948
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis of Nonalcoholic Steatohepatitis: An Overview.
    Parthasarathy G, Revelo X, Malhi H.
    Hepatol Commun; 2020 Apr 20; 4(4):478-492. PubMed ID: 32258944
    [Abstract] [Full Text] [Related]

  • 12. Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH.
    Guo Q, Furuta K, Lucien F, Gutierrez Sanchez LH, Hirsova P, Krishnan A, Kabashima A, Pavelko KD, Madden B, Alhuwaish H, Gao Y, Revzin A, Ibrahim SH.
    J Hepatol; 2019 Dec 20; 71(6):1193-1205. PubMed ID: 31433301
    [Abstract] [Full Text] [Related]

  • 13. Non-Alcoholic Fatty Liver Disease.
    Engin A.
    Adv Exp Med Biol; 2017 Dec 20; 960():443-467. PubMed ID: 28585211
    [Abstract] [Full Text] [Related]

  • 14. Decoding cell death signals in liver inflammation.
    Brenner C, Galluzzi L, Kepp O, Kroemer G.
    J Hepatol; 2013 Sep 20; 59(3):583-94. PubMed ID: 23567086
    [Abstract] [Full Text] [Related]

  • 15. Pathogenesis of Nonalcoholic Steatohepatitis.
    Machado MV, Diehl AM.
    Gastroenterology; 2016 Jun 20; 150(8):1769-77. PubMed ID: 26928243
    [Abstract] [Full Text] [Related]

  • 16. Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis.
    Gentilini A, Caligiuri A, Provenzano A, Marra F.
    Curr Mol Med; 2016 Jun 20; 16(8):710-720. PubMed ID: 27774883
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.
    Greuter T, Malhi H, Gores GJ, Shah VH.
    JCI Insight; 2017 Sep 07; 2(17):. PubMed ID: 28878132
    [Abstract] [Full Text] [Related]

  • 18. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, Carreras MC, Poderoso JJ, Gores GJ.
    Liver Int; 2015 Mar 07; 35(3):953-66. PubMed ID: 24750664
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions.
    Myint M, Oppedisano F, De Giorgi V, Kim BM, Marincola FM, Alter HJ, Nesci S.
    J Transl Med; 2023 Oct 26; 21(1):757. PubMed ID: 37884933
    [Abstract] [Full Text] [Related]

  • 20. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.